In the years after having a transplant using your own cells (autologous transplant), complications can develop. This presentation describes possible late complications, risk factors for each complication, ways that you can help minimize the risks, and strategies for managing any complications that do occur.

Autologous stem cell transplants are a treatment option primarily for patients with multiple myeloma and non-Hodgkin lymphoma. High-dose chemotherapy is part of the treatment and can destroy cancer cells as well as healthy blood cells. Although side effects do occur after an autologous stem cell transplant, most patients can expect a return to normal, healthy life after transplant.

Autologous transplants (using the patient’s own cells) are typically done for myeloma or lymphoma. This presentation reviews the potential complications that may arise from this procedure and provides numerous recommendations for how they can be managed or avoided.

Patients who undergo a stem cell transplant using their own cells (an autologous transplant) have an increased risk of heart disease, infection, pulmonary problems and sexual dysfunction. Careful monitoring and a healthy lifestyle can reduce the risk of developing serious problems.

Autologous transplants (transplant using your own cells) are most often used to treat patients with multiple myeloma, Hodgkin Disease and non-Hodgkin Lymphoma. Potential late effects after transplant require life-long monitoring to ensure a good quality of life.